Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research

Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market is Expected to Reach USD 75.2 Million Globally in 2018: Transparency Market Research PR Newswire ALBANY, New York, October 26, 2012 ALBANY, New York, October 26, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com), "Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market - Global Industry Analysis by Test Type and Age Group, Market Size, Share and Forecast, 2012 - 2018," the global Pap smear test market was valued at USD 28.0 million in 2011 and is expected to reach an estimated value of USD 31.4 million in 2018, growing at a CAGR of 1.7% from 2012 to 2018. The global edocervical curettage (ECC) procedures market was valued at USD 6.7 million in 2011 and is the fastest growing segment owing to its accuracy during cervical cancer diagnosis. Browse the full report at http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests- market.html A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual encounters, a rising number of organized cervical cancer programs initiated by governments and NGOs and the rising disposable income of consumers especially in the Asia Pacific region are some of the major growth drivers for the Pap smear tests market.